Sanofi Receives Bids from Private Equity Firms for $16B+ Consumer Health Business

Bids Received:
Sanofi has received separate offers from private equity firms PAI Partners and Clayton, Dubilier & Rice for its consumer health business.

Valuation:
The consumer health business is valued at approximately $16 billion or more.

Business Scope:
Sanofi's consumer health business includes over-the-counter medications and other healthcare products.

Market Impact:
The potential sale could significantly impact the pharmaceutical and healthcare industry, particularly in the consumer health sector.

Company Background:
Sanofi is a French multinational pharmaceutical and healthcare company with a diverse portfolio of prescription and over-the-counter medications.

Recent Developments:
Sanofi has also been in the news for its advancements in multiple sclerosis drug trials and its commitment to affordable insulin pens for diabetic patients.